Skip to content

A prospective cohort study of myositis specific antibodies and poor prognosis of juvenile dermatomyositis

A prospective cohort study of myositis specific antibodies and poor prognosis of juvenile dermatomyositis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030770
Enrollment
Unknown
Registered
2020-03-14
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Dermatomyositis

Interventions

MSA positive group vs. MSA negative group :N/A

Sponsors

The Affiliated Children's Hospital, Capital Institute of Pediatrics
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged < 18 years; 2. Diagnosed juvenile dermatomyositis, including dermatomyositis, polymyositis and clinical amyopathic dermatomyositis; 3. Parents/guardians agree that children should participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Merging other diseases that may cause muscle lesions and muscle weakness; 2. Immune abnormality caused by primary immunodeficiency or allergic constitution; 3. The patient is within the process of acute or chronic infection, or has a past history of active tuberculosis; HbsAg(+) or anti-HCV(+); 4. The patient has psychiisatric disorders or other reasons that can not cooperate.

Design outcomes

Primary

MeasureTime frame
Myositis antibody spectrum (including but not limited to anti-Jo-1, PL-7, PL-12, EJ, SRP, Mi2, MDA5, TIF1?, HMGCR, SSA/Ro52kD, SAE1/2, NXP2 antibodies);Childhood Myositis Assessment Scale;Cutaneous Assessment Tool for Myositis-Binary Method;Serum enzyme level (including CK, CKMB, LDH, HBDH, ALT, AST);other organs besides muscle;

Secondary

MeasureTime frame
Routine blood tests;urine routine examination;Stool routine examination;Liver function;renal function;Lipids;blood glucose;Serum electrolytes;Serum calcium;Serum phosphorus;ESR;CRP;SF;KL-6;ANA;cellular immunity;humoral immunity;cytokines;muscle MRI;electromyography;muscle tissue biopsy;pulmonary high-resolution CT;abdominal ultrasound;electrocardiogram;

Countries

China

Contacts

Public ContactJianguo Li

The Affiliated Children's Hospital, Capital Institute of Pediatrics

jianguo_li6@hotmail.com+86 13381055963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026